Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05868369 · ClinicalTrials.gov registry record · NA
The Effectiveness of Immersive Virtual Reality as a Pain Control Modality After Hip Arthroscopy
A NA study of Hip Pain Chronic, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 2
- Study locations
NCT05868369 is a NA study of Hip Pain Chronic that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 70 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT05868369, a NA study of Hip Pain Chronic, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 2
- Study locations
Study Summary
1. The purpose of the research is to assess the efficacy of postoperative immersive virtual reality (iVR) compared to a standard multimodal pain regimen including opioids and a local block on acute postoperative pain management following hip arthroscopy 2. The primary research procedures are medical record review for demographic information, head-mounted immersive virtual reality experience in PACU, and pre-operative and post-operative surveys 3. The study will enroll adult patients of all ages undergoing elective hip arthroscopy procedures for any diagnosis
Conditions Studied
Interventions
- DEVICE iVR Group
- DRUG Standard pain management regimen
Study Locations (2)
California
- Kerlan Jobe - Los Angeles
- Kerlan Jobe - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2028-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05868369
The ClinicalTrials.gov registry entry for NCT05868369 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hip Pain Chronic appearing as the primary indexed condition, and to 2 interventions - of which iVR Group is the first listed.
NCT05868369 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05868369 about?
NCT05868369 is a clinical study titled "The Effectiveness of Immersive Virtual Reality as a Pain Control Modality After Hip Arthroscopy". 1. The purpose of the research is to assess the efficacy of postoperative immersive virtual reality (iVR) compared to a standard multimodal pain regimen including opioids and a local block on acute postoperative pain management following hip arthroscopy 2. The primary research procedures are medical...
What is the current status of trial NCT05868369?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2023-11-01. Estimated completion is 2028-08.
What conditions does trial NCT05868369 study?
This clinical trial studies the following conditions: Hip Pain Chronic.
What interventions are being tested in trial NCT05868369?
The interventions under investigation include: iVR Group (DEVICE), Standard pain management regimen (DRUG).
Who is sponsoring clinical trial NCT05868369?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05868369 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Pain Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.